| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | 2 | 1 | — | 1 | — |
| Sell | — | — | — | — | — | — | — | — | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡ |
|
| 2026 | 1.03 |
—
—
—
|
| 2025 | 1.00 |
—
—
—
—
|
| 2024 | 0.96 |
—
—
—
—
|
| 2023 | 0.92 |
—
—
—
—
|
| 2022 | 0.96 |
—
—
—
—
|
| 2021 | 0.89 |
—
—
—
—
|
| 2020 | 0.82 |
—
—
—
—
|
| 2019 | 0.75 |
—
—
—
—
|
| 2018 | 0.68 |
—
—
—
—
|
| 2017 | 0.62 |
—
—
—
—
|
| 2016 | 0.55 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 366.40 | 381.10 | 264.00 | 209.70 |
| Receivables | 534.20 | 514.40 | 513.10 | 607.10 |
| Inventory | 982.30 | 960.30 | 1,024.90 | 990.70 |
| Other | 162.80 | 151.60 | 172.20 | 267.50 |
| 2,045.70 | 2,007.40 | 1,974.20 | 2,075.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 568.10 | 513.90 | 524.60 | 518.90 |
| ST’ Debt | — | 499.60 | — | — |
| Other | 632.30 | 588.80 | 547.00 | 511.60 |
| 1,200.40 | 1,602.30 | 1,071.60 | 1,030.50 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,011.30 | 1,153.90 | — | — |
—
|
| ’25 | 1,033.10 | 1,203.30 | 1,149.20 | 1,077.60 |
4,463.20
|
| ’24 | 1,109.60 | 1,240.00 | 1,155.30 | 1,104.10 |
4,609.00
|
| ’23 | 1,040.00 | 1,163.70 | 1,261.20 | 1,161.30 |
4,626.20
|
| ’22 | 1,140.20 | 1,255.40 | 1,195.50 | 1,131.90 |
4,723.00
|
| ’21 | 1,771.00 | 1,936.10 | 1,986.30 | (892.30) |
4,801.10
|
| ’20 | 1,402.70 | 1,375.80 | 1,652.10 | (809.30) |
3,621.30
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (119.20) | 202.80 | — | — |
—
|
| ’25 | (83.40) | 149.40 | 204.40 | 208.20 |
478.60
|
| ’24 | (71.30) | 261.50 | 205.30 | 272.30 |
667.80
|
| ’23 | 76.10 | 427.50 | 332.00 | 220.20 |
1,055.80
|
| ’22 | (183.10) | 225.00 | 246.90 | 277.50 |
566.30
|
| ’21 | (69.20) | 331.90 | 168.10 | 257.90 |
688.70
|
| ’20 | (13.80) | 274.30 | 246.30 | 318.90 |
825.70
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (129.70) | 179.30 | — | — |
—
|
| ’25 | (112.60) | 118.70 | 177.00 | 190.60 |
373.70
|
| ’24 | (135.90) | 222.70 | 175.60 | 239.00 |
501.40
|
| ’23 | 33.50 | 360.60 | 268.60 | 139.40 |
802.10
|
| ’22 | (235.90) | 170.20 | 187.50 | 206.60 |
328.40
|
| ’21 | (92.90) | 291.50 | 120.90 | 156.90 |
476.40
|
| ’20 | (39.20) | 258.90 | 222.40 | 234.70 |
676.80
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.20 | (0.19) | — | — |
—
|
| ’25 | 0.42 | 0.83 | 0.59 | 0.63 |
2.47
|
| ’24 | 0.76 | 1.06 | 1.09 | 0.84 |
3.75
|
| ’23 | 0.66 | 0.80 | 1.07 | 0.64 |
3.17
|
| ’22 | 1.34 | 1.46 | 1.57 | 0.85 |
5.23
|
| ’21 | 1.26 | 1.55 | 1.45 | 1.28 |
5.54
|
| ’20 | 0.77 | 0.83 | 1.17 | 1.16 |
3.94
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 45.26 | 54.10 | 62.54 | 44.04 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 92.66 | 80.33 | 90.54 | 75.82 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11,200 | 11,700 | 11,000 | 10,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.42 | 0.40 | 0.42 | 0.45 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,723.00 | 4,626.20 | 4,609.00 | 4,463.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 40.93% | 41.32% | 44.83% | 44.57% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 667.10 | 517.90 | 605.50 | 405.00 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.12% | 11.19% | 13.14% | 9.07% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 686.70 | 404.50 | 471.90 | 298.80 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 191.60 | 168.80 | 193.60 | 194.40 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.25 | 36.46 | 36.93 | 36.98 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.23 | 3.17 | 3.75 | 2.47 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.35 | 8.32 | 5.35 | 3.97 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.83) | (2.00) | (1.33) | (0.87) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.52 | 6.32 | 4.02 | 3.10 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.02 | 18.07 | 19.41 | 19.79 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 130.30 | 126.90 | 124.80 | 120.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.11 | 23.82 | 18.22 | 20.25 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.60 | 2.07 | 1.85 | 1.35 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.62 | 4.18 | 3.52 | 2.53 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.03 | 2.70 | 2.35 | 1.98 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.19 | 15.56 | 21.58 | 23.60 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 566.30 | 1,055.80 | 667.80 | 478.60 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (237.90) | (253.70) | (166.40) | (104.90) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 328.40 | 802.10 | 501.40 | 373.70 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 915.70 | 845.30 | 405.10 | 902.60 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,673.50 | 2,670.10 | 2,673.30 | 2,544.90 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,031.00 | 2,303.70 | 2,292.20 | 2,280.90 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,086.90 | 2,293.40 | 2,422.00 | 2,388.60 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.77% | 6.38% | 7.19% | 4.57% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.75% | 8.36% | 9.78% | 6.91% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26.66% | 18.47% | 20.02% | 12.42% | ‡‡‡‡‡ | — | — |
ROE
|
Fortune Brands Innovations (FBIN), a key player in home improvement products like faucets and security solutions, demonstrates balance sheet resilience amid housing market cycles and post-spin-off streamlining, but its revenue stability around $4.6 billion masks vulnerabilities to interest rates and demand softness. Gross margins have impressively expanded to 44.8% through operational efficiencies, supporting EBT growth and robust free cash flow—peaking at $802 million in 2023—while manageable net debt at $2.3 billion equates to about 50% of equity. However, fluctuating net income, insider selling, and a cyclical profile tied to U.S. housing starts warrant caution, with shares trading in a subdued range after pandemic highs.
Per-share metrics reflect prudent capital management, with shares outstanding down 19% since 2016, lifting EPS to $3.75 and ROE to 20%, though ROA lags at 7.2% signaling asset inefficiencies. Valuation appears fair at a trailing PE of 18 and PS of 1.85, with analyst targets implying modest 10% upside on average, but forward EPS projections show a 2025 dip before recovery—contingent on margin stability and housing rebound.
Key downside risks include prolonged high rates eroding affordability, potential revenue misses amplifying EPS erosion by 20-30%, and untested margin gains in downturns. For risk-averse investors, FBIN suits a hold strategy emphasizing steady ROE and debt control, but macro reversals could pressure the portfolio-pure housing exposure. Read the full analysis for deeper risk assessments and projections.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.